Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Most art galleries are closed, but you can still tour this one — with a robot

Add as a preferred source on Google
Hastings contemporary robot default 2

Museums and art galleries have long encouraged an air of monastic silence so that visitors can enjoy the artworks and other offerings without being disturbed. But the curators running these places probably didn’t want total silence at the cost of any and all visitors coming through their doors. That’s one of the many scenarios unfolding as a result of the current coronavirus pandemic, however. To keep in line with mandated social distancing, museums, and art galleries throughout the world are either finding themselves shuttered by law or, in the rare cases they remain open, with drastically reduced footfall.

Recommended Videos

An art gallery in the United Kingdom might have the right idea, though — and it’s one that, should it be adopted by others worldwide, could allow people to continue enjoying the beauty of great artworks without risking their health or curfew laws. The country’s Hastings Contemporary art gallery has teamed up with the Bristol Robotics Laboratory to carry out tours of the museum using a telepresence robot. These two-wheeled robots, which resemble iPads mounted on Segways, let people tune in to view real-time guided tours of the currently closed gallery.

“Our initial idea was to help people who lived in places like care homes to have access to the gallery,” Will Barrett, communications and marketing manager at Hastings Contemporary, told Digital Trends. “When the pandemic first started to roll around, we thought it would be good to bring this forward and accelerate the use of it because, while we’re in lockdown, it would mean that people can still come into the gallery.”

Hastings Gallery telepresence robot 1
Image used with permission by copyright holder

Barrett acknowledged that art galleries can simply shift to presenting artwork online, but stressed that this is not the same experience as a curated gallery, in which artworks are carefully placed in a physical environment. He also said that it makes an important point, harking back to the inclusive origins of the project as an attempt to widen participation.

“[Right now], many people are living or sharing lived experiences very similar to [that of] many disabled people in that they can’t easily leave their houses,” he said. “So it’s a means of exploring and sharing the problems and difficulties of being someone who has to stay home. From an operational point of view, it’s really inspired us to think about how everyone should have the opportunity, as a publicly subsidized institution, to experience art.”

Currently, the museum is preparing to launch its first tours. There will initially be two tours on a Tuesday afternoon and two on a Thursday, with people able to tune into online. The feedback from these will then be used to further hone the experience.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Checking body medication levels may now be as easy as sucking on a peach-flavoured lollipop
Forget the clinic swab; this lollipop wants a lick
Lollylab

Checking your body’s medication levels is usually no one’s idea of fun. Now researchers are trying to change that with Lollylab, a candy-coated, lollipop-like device that can collect saliva and measure levels of acetaminophen in under two minutes.

The prototype created by researchers whose work was published in ACS Sensors transforms a familiar object into a miniature testing device. In a pilot study, six adults ingested the peach-flavored Lollylab before and one hour after a standard 650-milligram dose of acetaminophen. The device repeatedly detected the pain reliever in their saliva, and participants reported it was more comfortable and easier to use than traditional saliva swabs.

Read more
A US state just approved an AI doctor. For now, it’ll only prescribe acne cures.
Aside from acne, Nolla's AI can also handle redness, fine lines and wrinkles, hyperpigmentation and dark spots, and under-eye bags.
Nolla Derm AI doctor app.

The first AI doctor is here. Despite all the skepticism and risks associated with AI models going haywire, the state of Utah just approved Nolla Health, a company that is providing an AI healthcare expert capable of writing prescriptions without any human in the chain. For now, it will only write acne prescriptions for Utah residents over 18 years of age, willing to pay a token monthly subscription fee that's lighter than your Spotify bill.

The big push here is that the Nolla Derm app will reduce the costs of medical consultation, save users the hassle of clinic visits, and take out the problem of waitlisting from the entire healthcare equation. “Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols,” writes the company. 

Read more
AI’s massive appetite could make cheap smartphones much harder to find
The smartphone aisle is getting pricier, and AI may be partly to blame.
Electronics, Mobile Phone, Phone

Buying a genuinely cheap smartphone could soon become a lot harder, and the reason has little to do with what’s happening inside the smartphone industry itself. The enormous amount of hardware being poured into AI data centers is pressuring global memory supplies. That has helped drive up the cost of making phones, and manufacturers appear increasingly reluctant to absorb those extra costs at the cheapest end of the market.

According to Counterpoint Research, prices of existing smartphones have increased by around 15% globally this year, while newly launched devices are roughly 25% more expensive than comparable models from last year. The impact hasn't been equal everywhere, either. Smartphone prices have climbed 21% in India and 19% across Asia-Pacific, compared with just 5% in the US.

Read more